MedicineHumansColistinMaleFemaleMiddle Aged
Risk factors for mortality in febrile neutropenic patients treated with colistin.
Cumali Yalçin, Vildan Özkocaman, Tuba Ersal, Bedrettin Orhan, Ömer Candar, Sinem Çubukçu, Tuba Güllü Koca, Fazil Çağri Hunutlu, Merve Nur Akyol, Esra Kazak, Cüneyt Özakin, Halis Akalin, Fahir Özkalemkaş
Published: 202510.1097/MD.0000000000044841
Abstract
This study aimed to investigate the prognostic factors of febrile neutropenic patients during colistin treatment. The indications for starting colistin treatment during febrile neutropenia (FN) episodes, nephrotoxicity, FN-related mortality rates, an…
Preview only. Read the full abstract at the source